NASDAQ : KRYS
Krystal Biotech, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 332.29 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.84B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Krystal Biotech, Inc. (KRYS) reported revenue of 470.02M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 470.02M | 389.13M | 290.51M | 50.70M | ||
| Cost of Revenue | 26.91M | 23.05M | 20.06M | 3.09M | ||
| Gross Profit | 443.12M | 366.08M | 270.45M | 47.60M | ||
| Selling, General & Admin | 156.06M | 146.74M | 113.63M | 98.29M | 78.83M | 41.99M |
| Research & Development | 59.53M | 58.05M | 53.58M | 46.43M | 42.46M | 27.88M |
| Operating Expenses | 215.59M | 204.79M | 167.21M | 144.72M | 121.30M | 69.88M |
| Operating Income | 227.52M | 161.29M | 103.25M | -97.12M | -121.30M | -69.88M |
| Interest Expense | -1.49M | |||||
| Interest & Investment Income | 6.86M | 28.18M | 29.61M | 22.51M | 5.22M | 197.00K |
| EBT Excluding Unusual Items | 258.80M | 189.47M | 132.86M | -74.60M | -116.08M | -71.17M |
| Gain (Loss) on Sale of Assets | 100.00M | |||||
| Legal Settlements | -37.50M | -12.50M | -25.00M | |||
| Pretax Income | 258.80M | 189.47M | 95.36M | 12.90M | -139.97M | -69.57M |
| Income Tax Expense | 33.63M | -15.36M | 6.20M | 1.97M | ||
| Net Income | 225.17M | 204.83M | 89.16M | 10.93M | -139.97M | -69.57M |
| Net Income to Common | 225.17M | 204.83M | 89.16M | 10.93M | -139.97M | -69.57M |
| Shares Outstanding (Basic) | 29.38M | 28.94M | 28.59M | 27.15M | 25.49M | 22.20M |
| Shares Outstanding (Diluted) | 30.59M | 29.95M | 29.74M | 27.75M | 25.49M | 22.20M |
| EPS (Basic) | 7.66 | 7.08 | 3.12 | 0.40 | -5.49 | -3.13 |
| EPS (Diluted) | 7.36 | 6.84 | 3.00 | 0.39 | -5.49 | -3.13 |
| Free Cash Flow | 310.08M | 188.91M | 119.18M | -100.60M | -153.55M | -116.27M |
| Free Cash Flow Per Share | 10.14 | 6.31 | 4.01 | -3.62 | -6.02 | -5.24 |
| Gross Margin | 94.27% | 94.08% | 93.09% | 93.90% | ||
| Operating Margin | 48.41% | 41.45% | 35.54% | -191.56% | ||
| Profit Margin | 47.91% | 52.64% | 30.69% | 21.56% | ||
| Free Cash Flow Margin | 65.97% | 48.55% | 41.02% | -198.43% | ||
| EBITDA | 232.43M | 162.92M | 105.72M | -93.21M | -118.65M | -67.11M |
| EBITDA Margin | 49.45% | 41.87% | 36.39% | -183.85% | ||
| D&A For EBITDA | 4.91M | 1.62M | 2.47M | 3.91M | 2.64M | 2.77M |
| EBIT | 227.52M | 161.29M | 103.25M | -97.12M | -121.30M | -69.88M |
| EBIT Margin | 48.41% | 41.45% | 35.54% | -191.56% | ||
| Effective Tax Rate | 13.00% | 6.50% | 15.24% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 462.84M | 496.30M | 344.87M | 358.33M | 161.90M | 341.25M |
| Short-Term Investments | 449.01M | 331.49M | 252.65M | 173.85M | 217.27M | 96.85M |
| Cash & Short-Term Investments | 911.85M | 827.79M | 597.52M | 532.18M | 379.17M | 438.10M |
| Receivables | 133.12M | 127.42M | 104.75M | 42.04M | ||
| Inventory | 50.79M | 40.48M | 26.51M | 6.99M | ||
| Prepaid Expenses | 26.01M | 28.91M | 13.27M | 6.71M | 4.61M | 4.17M |
| Total Current Assets | 1.12B | 1.02B | 742.04M | 587.91M | 383.78M | 442.27M |
| Property, Plant & Equipment | 158.90M | 158.01M | 161.45M | 168.23M | 169.73M | 119.58M |
| Long-Term Investments | 282.30M | 128.07M | 152.11M | 61.95M | 4.62M | 64.37M |
| Long-Term Deferred Tax Assets | 22.82M | 22.82M | ||||
| Other Long-Term Assets | 269.00K | 287.00K | 231.00K | 263.00K | 324.00K | 74.00K |
| Total Assets | 1.59B | 1.33B | 1.06B | 818.36M | 558.45M | 626.29M |
| Accounts Payable | 6.73M | 3.24M | 4.99M | 4.13M | 3.98M | 8.40M |
| Accrued Expenses | 133.60M | 81.25M | 52.77M | 18.15M | 11.54M | 6.52M |
| Current Portion of Leases | 1.82M | 1.77M | 1.22M | 1.47M | 1.56M | 1.04M |
| Current Income Taxes Payable | 10.92M | 4.29M | 1.96M | 43.00K | 83.00K | |
| Other Current Liabilities | 5.77M | 38.73M | 7.38M | 11.72M | 9.69M | |
| Total Current Liabilities | 142.14M | 102.94M | 102.00M | 33.09M | 28.85M | 25.74M |
| Long-Term Leases | 6.77M | 7.57M | 6.04M | 6.62M | 7.37M | 6.98M |
| Other Long-Term Liabilities | 1.56M | 3.72M | 1.42M | |||
| Total Liabilities | 150.47M | 114.23M | 109.46M | 39.71M | 36.22M | 32.72M |
| Additional Paid-In Capital | 1.25B | 1.19B | 1.13B | 1.05B | 803.72M | 734.52M |
| Retained Earnings | 197.93M | 24.16M | -180.67M | -269.83M | -280.76M | -140.78M |
| Comprehensive Income & Other | -9.24M | 1.14M | -190.00K | 638.00K | -728.00K | -163.00K |
| Total Common Equity | 1.44B | 1.22B | 946.38M | 778.64M | 522.23M | 593.58M |
| Shareholders' Equity | 1.44B | 1.22B | 946.38M | 778.64M | 522.23M | 593.58M |
| Total Liabilities & Equity | 1.59B | 1.33B | 1.06B | 818.36M | 558.45M | 626.29M |
| Total Debt | 8.59M | 9.34M | 7.26M | 8.09M | 8.93M | 8.02M |
| Net Cash (Debt) | 903.26M | 946.52M | 742.37M | 586.04M | 374.86M | 494.44M |
| Net Cash Per Share | 29.52 | 31.60 | 24.96 | 21.12 | 14.70 | 22.28 |
| Filing Date Shares Outstanding | 29.63M | 29.23M | 28.81M | 28.29M | 25.76M | 25.21M |
| Total Common Shares Outstanding | 29.63M | 29.19M | 28.79M | 28.24M | 25.76M | 25.21M |
| Working Capital | 979.62M | 921.66M | 640.05M | 554.82M | 354.93M | 416.53M |
| Book Value Per Share | 48.45 | 41.78 | 32.87 | 27.58 | 20.27 | 23.55 |
| Tangible Book Value | 1.44B | 1.22B | 946.38M | 778.64M | 522.23M | 593.58M |
| Tangible Book Value Per Share | 48.45 | 41.78 | 32.87 | 27.58 | 20.27 | 23.55 |
| Buildings | 109.24M | 111.44M | 111.18M | |||
| Machinery | 37.48M | 34.19M | 30.49M | 12.93M | 6.51M | |
| Construction In Progress | 8.11M | 5.78M | 7.29M | 131.33M | 104.34M | |
| Leasehold Improvements | 27.23M | 25.67M | 25.07M | 24.22M | 5.72M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 225.17M | 204.83M | 89.16M | 10.93M | -139.97M | -69.57M |
| Depreciation & Amortization | 5.74M | 2.45M | 3.21M | 4.81M | 3.38M | 2.77M |
| Loss (Gain) From Sale of Assets | -100.00M | |||||
| Loss (Gain) From Sale of Investments | -4.89M | -6.45M | -7.78M | -7.28M | 100.00K | |
| Stock-Based Compensation | 55.47M | 54.51M | 49.13M | 39.93M | 33.23M | 15.32M |
| Other Operating Activities | 2.94M | -18.06M | 4.15M | 1.32M | 34.00K | 1.04M |
| Change in Accounts Receivable | -4.00M | -22.12M | -62.71M | -42.04M | ||
| Change in Inventory | -4.26M | -6.29M | -11.91M | -4.47M | ||
| Change in Accounts Payable | 4.11M | 826.00K | 1.01M | -101.00K | -1.25M | 712.00K |
| Change in Income Taxes | 4.13M | -12.39M | -1.62M | |||
| Change in Other Net Operating Assets | 39.51M | 3.55M | 60.76M | 8.09M | 3.91M | 1.79M |
| Operating Cash Flow | 323.93M | 200.87M | 123.42M | -88.80M | -100.57M | -47.94M |
| Capital Expenditures | -13.85M | -11.95M | -4.24M | -11.80M | -52.98M | -68.34M |
| Sale of Property, Plant & Equipment | 435.00K | 100.00M | ||||
| Investment in Securities | -258.14M | -46.90M | -159.20M | -5.56M | -61.10M | -158.43M |
| Investing Cash Flow | -271.99M | -58.42M | -163.44M | 82.64M | -114.08M | -226.77M |
| Issuance of Common Stock | 40.77M | 22.66M | 32.40M | 203.50M | 36.00M | 355.64M |
| Repurchase of Common Stock | -17.10M | -13.96M | -5.39M | -749.00K | -649.00K | |
| Other Financing Activities | -7.96M | |||||
| Financing Cash Flow | 23.67M | 8.71M | 27.01M | 202.75M | 35.35M | 347.69M |
| Foreign Exchange Rate Adjustments | -5.38M | 286.00K | -458.00K | -156.00K | -41.00K | |
| Net Cash Flow | 70.24M | 151.44M | -13.46M | 196.43M | -179.35M | 72.98M |
| Free Cash Flow | 310.08M | 188.91M | 119.18M | -100.60M | -153.55M | -116.27M |
| Free Cash Flow Margin | 65.97% | 48.55% | 41.02% | -198.43% | ||
| Free Cash Flow Per Share | 10.14 | 6.31 | 4.01 | -3.62 | -6.02 | -5.24 |
| Levered Free Cash Flow | 183.29M | 93.93M | 92.99M | -74.54M | -90.02M | -85.35M |
| Unlevered Free Cash Flow | 183.29M | 93.93M | 92.99M | -74.54M | -90.02M | -84.41M |
| Cash Income Tax Paid | 24.52M | 15.67M | 5.67M | |||
| Change in Working Capital | 39.50M | -36.42M | -14.46M | -38.52M | 2.66M | 2.51M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 8.38B | 7.15B | 4.51B | 3.50B | 2.04B | 1.74B |
| Enterprise Value | 7.48B | 6.29B | 3.82B | 2.91B | 1.64B | 1.39B |
| Last Close Price | 332.29 | 246.54 | 156.66 | 124.06 | 79.22 | 69.95 |
| PE Ratio | 38.47 | 34.90 | 50.53 | 320.10 | ||
| Forward PE | 33.83 | 34.89 | 33.30 | |||
| PS Ratio | 20.93 | 18.37 | 15.51 | 69.02 | ||
| PB Ratio | 7.24 | 5.86 | 4.76 | 4.49 | 3.91 | 2.94 |
| P/TBV Ratio | 6.85 | 5.86 | 4.76 | 4.49 | 3.91 | 2.94 |
| P/FCF Ratio | 31.72 | 37.84 | 37.80 | |||
| P/OCF Ratio | 30.36 | 35.59 | 36.51 | |||
| PEG Ratio | 0.91 | 0.61 | ||||
| EV/Sales Ratio | 19.00 | 16.18 | 13.14 | 57.38 | ||
| EV/EBITDA Ratio | 38.43 | 38.63 | 36.12 | |||
| EV/EBIT Ratio | 39.26 | 39.02 | 36.99 | |||
| EV/FCF Ratio | 28.81 | 33.32 | 32.04 | |||
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| Debt / EBITDA Ratio | 0.04 | 0.06 | 0.07 | |||
| Debt / FCF Ratio | 0.03 | 0.05 | 0.06 | |||
| Net Debt / Equity Ratio | -0.63 | -0.78 | -0.78 | -0.75 | -0.72 | -0.83 |
| Net Debt / EBITDA Ratio | -3.89 | -5.81 | -7.02 | 6.29 | 3.16 | 7.37 |
| Net Debt / FCF Ratio | -2.91 | -5.01 | -6.23 | 5.83 | 2.44 | 4.25 |
| Asset Turnover | 0.33 | 0.33 | 0.31 | 0.07 | ||
| Inventory Turnover | 0.61 | 0.69 | 1.20 | |||
| Quick Ratio | 7.35 | 9.28 | 6.88 | 17.35 | 13.14 | 17.02 |
| Current Ratio | 7.89 | 9.95 | 7.28 | 17.77 | 13.30 | 17.18 |
| Return on Equity (ROE) | 17.50% | 18.91% | 10.34% | 1.68% | -25.09% | -15.71% |
| Return on Assets (ROA) | 10.06% | 8.44% | 6.89% | -8.82% | -12.80% | -9.32% |
| Return on Invested Capital (ROIC) | 37.54% | 42.60% | 31.62% | -40.50% | -76.89% | -74.23% |
| Return on Capital Employed (ROCE) | 15.80% | 13.10% | 10.80% | -12.40% | -22.90% | -11.60% |
| Earnings Yield | 2.60% | 2.86% | 1.98% | 0.31% | -6.86% | -3.99% |
| FCF Yield | 3.15% | 2.64% | 2.65% | -2.88% | -7.53% | -6.67% |
| Buyback Yield / Dilution | -2.47% | -0.71% | -7.16% | -8.87% | -14.85% | -18.15% |